carbon monoxide has been researched along with Neurodegenerative Diseases in 14 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen sulfide (H2S)has emerged as pivotal signaling molecules since it is recognized as the third gasotransmitter together with nitric oxide and carbon monoxide." | 2.55 | [The Molecular Switches and Atomic Biological Mechanisms Underlying the Physiological and Pathophysio-logical Effects of Hydrogen Sulfide to Regulate Its "Receptors"]. ( Cai, WJ; Li, XH; Tao, BB; Wang, MJ; Xue, WL; Zhu, YC, 2017) |
| " It is argued that the hormetic dose response provides the central underpinning of neuroprotective responses, providing a framework for explaining the common quantitative features of their dose-response relationships, their mechanistic foundations, and their relationship to the concept of biological plasticity, as well as providing a key insight for improving the accuracy of the therapeutic dose of pharmaceutical agents within the highly heterogeneous human population." | 2.46 | Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. ( Calabrese, EJ; Calabrese, V; Cornelius, C; Dinkova-Kostova, AT; Mattson, MP, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Gottfried, I | 1 |
| Schottlender, N | 1 |
| Ashery, U | 1 |
| Parks, RM | 1 |
| Nunez, Y | 1 |
| Balalian, AA | 1 |
| Gibson, EA | 1 |
| Hansen, J | 1 |
| Raaschou-Nielsen, O | 1 |
| Ketzel, M | 1 |
| Khan, J | 1 |
| Brandt, J | 1 |
| Vermeulen, R | 1 |
| Peters, S | 1 |
| Goldsmith, J | 1 |
| Re, DB | 1 |
| Weisskopf, MG | 1 |
| Kioumourtzoglou, MA | 1 |
| Rodkin, S | 1 |
| Nwosu, C | 1 |
| Sannikov, A | 1 |
| Tyurin, A | 1 |
| Chulkov, VS | 1 |
| Raevskaya, M | 1 |
| Ermakov, A | 1 |
| Kirichenko, E | 1 |
| Gasanov, M | 1 |
| Xue, WL | 1 |
| Cai, WJ | 1 |
| Tao, BB | 1 |
| Wang, MJ | 1 |
| Li, XH | 1 |
| Zhu, YC | 1 |
| Lee, H | 1 |
| Choi, YK | 1 |
| Peers, C | 1 |
| Boyle, JP | 1 |
| Smolle-Jüttner, FM | 1 |
| Calabrese, V | 3 |
| Cornelius, C | 2 |
| Mancuso, C | 1 |
| Lentile, R | 1 |
| Stella, AM | 2 |
| Butterfield, DA | 2 |
| Dinkova-Kostova, AT | 1 |
| Calabrese, EJ | 1 |
| Mattson, MP | 1 |
| Bishop, A | 1 |
| Cashman, NR | 1 |
| Takeda, A | 1 |
| Itoyama, Y | 1 |
| Kimpara, T | 1 |
| Zhu, X | 1 |
| Avila, J | 1 |
| Dwyer, BE | 1 |
| Perry, G | 1 |
| Smith, MA | 1 |
| Scapagnini, G | 1 |
| Cuadrado, A | 1 |
| Rojo, AI | 1 |
| Sharma, HS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cognitive Improvement After cARotid stEnting in HyperBaric Oxygen Therapy Trial (CARE-HBOT)[NCT05980195] | 90 participants (Anticipated) | Interventional | 2023-08-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for carbon monoxide and Neurodegenerative Diseases
| Article | Year |
|---|---|
Hyperbaric Oxygen Treatment-From Mechanisms to Cognitive Improvement.
Topics: Aged; Brain; Carbon Monoxide; Cognition; Humans; Hyperbaric Oxygenation; Inflammation; Mitochondria; | 2021 |
The Role of Gasotransmitter-Dependent Signaling Mechanisms in Apoptotic Cell Death in Cardiovascular, Rheumatic, Kidney, and Neurodegenerative Diseases and Mental Disorders.
Topics: Apoptosis; Carbon Monoxide; Gasotransmitters; Humans; Hydrogen Sulfide; Kidney; Mental Disorders; Ne | 2023 |
[The Molecular Switches and Atomic Biological Mechanisms Underlying the Physiological and Pathophysio-logical Effects of Hydrogen Sulfide to Regulate Its "Receptors"].
Topics: Asthma; Atherosclerosis; Carbon Monoxide; Cardiovascular System; Humans; Hydrogen Sulfide; Hypertens | 2017 |
Regenerative Effects of Heme Oxygenase Metabolites on Neuroinflammatory Diseases.
Topics: Bilirubin; Brain-Derived Neurotrophic Factor; Carbon Monoxide; Heme Oxygenase (Decyclizing); Humans; | 2018 |
Oxidative modulation of K+ channels in the central nervous system in neurodegenerative diseases and aging.
Topics: Aging; Animals; Apoptosis; Carbon Monoxide; Central Nervous System; Gasotransmitters; Humans; Hydrog | 2015 |
Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.
Topics: Animals; Carbon Monoxide; Cell Membrane; Dose-Response Relationship, Drug; Heme Oxygenase (Decyclizi | 2010 |
Induced adaptive resistance to oxidative stress in the CNS: a discussion on possible mechanisms and their therapeutic potential.
Topics: Adaptation, Physiological; Carbon Monoxide; Central Nervous System; Drug Resistance; Free Radicals; | 2003 |
Heme catabolism and heme oxygenase in neurodegenerative disease.
Topics: Carbon Monoxide; Heme; Heme Oxygenase (Decyclizing); Humans; Iron; Isoenzymes; Molecular Structure; | 2004 |
Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance.
Topics: Aging; Antioxidants; Brain; Carbon Monoxide; Gene Expression Regulation, Enzymologic; Heme Oxygenase | 2004 |
Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections.
Topics: Alzheimer Disease; Animals; Biliverdine; Brain; Carbon Monoxide; Central Nervous System Infections; | 2008 |
4 other studies available for carbon monoxide and Neurodegenerative Diseases
| Article | Year |
|---|---|
Long-term Traffic-related Air Pollutant Exposure and Amyotrophic Lateral Sclerosis Diagnosis in Denmark: A Bayesian Hierarchical Analysis.
Topics: Air Pollutants; Air Pollution; Amyotrophic Lateral Sclerosis; Bayes Theorem; Carbon Monoxide; Case-C | 2022 |
[CO intoxication: what to do after the acute episode?].
Topics: Brain; Brain Damage, Chronic; Carbon Monoxide; Carbon Monoxide Poisoning; Cardiomyopathies; Dementia | 2014 |
Redox homeostasis and cellular stress response in aging and neurodegeneration.
Topics: Acetylcarnitine; Aging; Animals; Carbon Monoxide; Gene Regulatory Networks; Heme Oxygenase-1; Homeos | 2010 |
Neurodegeneration and regeneration in the CNS. New roles of heat shock proteins, nitric oxide and carbon monoxide.
Topics: Carbon Monoxide; Central Nervous System; Heat-Shock Proteins; Humans; Neurodegenerative Diseases; Ni | 2000 |